Medicine and Dentistry
Transgender
100%
Pediatrics
50%
Adolescent
44%
Sinecatechins
33%
Carcinoma
33%
Cervix
33%
Adnexal Mass
33%
Hypersensitivity
33%
Giant Condyloma Acuminatum
33%
Tumor Marker
33%
Wart Virus
33%
Adenomyoma
33%
Anatomy
33%
Human Immunodeficiency Virus
33%
Erythema Multiforme
33%
Progesterone
33%
Janus Kinase Inhibitor
33%
Cryopreservation
33%
Adolescence
33%
Malignant Neoplasm
31%
Clinician
30%
Combination Therapy
28%
Gestagen
22%
Vagina Bleeding
16%
Vaginitis
16%
Lichen Sclerosus
16%
Strangury
16%
Outpatient
16%
Genital Ulcer
16%
Vulvovaginitis
16%
Vaginal Lavage
13%
Luteal Phase
11%
Cervical Cancer
11%
Primary Health Care
11%
Pathophysiology
11%
Quality of Care
11%
Gender Identity Disorder
11%
Immune Response
11%
Oral Mucositis
11%
Prevalence
11%
Medical Care
11%
Disease
11%
Awareness
11%
Tumor Antigen
8%
Fertility Preservation
8%
Lactate Dehydrogenase
8%
Surgical Technique
8%
Chorionic Gonadotropin Beta Subunit
8%
Heat Map
6%
Beta Defensin 2
6%
Keyphrases
Sexually Inactive
33%
Pediatric
33%
Obstetrics and Gynaecology
33%
Cross-sex Hormones
33%
Progestogen Hypersensitivity
33%
Progesterone Hypersensitivity
33%
Giant Condyloma
33%
Tumor Marker
33%
Juvenile Cystic Adenomyoma
33%
Adnexal Mass
33%
Transgender
33%
Sinecatechins
28%
Obstetrician-gynecologists
22%
Semen Quality Parameters
16%
Benign Mass
12%
Surgical Skills
11%
Cervical Ectopy
11%
Vaginal Lavage
11%
Quality Healthcare
11%
Medical Providers
11%
Medical Treatment
11%
Primary Care Setting
11%
Screening Recommendations
11%
Degenerating Fibroid
11%
Standard of Care
11%
Medical Care
11%
Gender Dysphoria
11%
Surgical Experience
11%
Individual Account
11%
Malignant Mass
8%
Female Youth
8%
Transgender Adolescents
8%
Carbohydrate Antigen 125 (CA125)
8%
Alpha-fetoprotein
8%
Surgical Procedures
8%
Beta Human Chorionic Gonadotropin (β-HCG)
8%
Lactate Dehydrogenase
8%
Screening Mechanism
6%
Immunocompromised Population
6%
Labial Adhesion
6%
Political Barrier
6%
Gender-affirming Hormone Therapy
6%
HIV Susceptibility
5%
Tissue Inhibitor of Matrix metalloproteinase-2
5%
MMP-8
5%
Immune Clustering
5%
TZM-bl Cells
5%
